Navigation Links
NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
Date:9/2/2008

fixation products and its R&D pipeline emphasizes both MAS and motion preservation.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to: the uncertain process of seeking regulatory approval or clearance for NuVasive's products or devices, including risks that such process could be significantly delayed; the possibility that the FDA may require significant changes to NuVasive's products or clinical studies; the risk that products may not perform as intended and may therefore not achieve commercial success; the risk that competitors may develop superior products or may have a greater market position enabling more successful commercialization; the risk that additional clinical data may call into question the benefits of NuVasive's products to patients, hospitals and surgeons; and other risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at http://www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Contact:

Kevin C. O'Boyle

EVP & Chief Financial Officer

NuVasive, Inc.

858-909-1800

investorrelations@nuvasive.com

Investors:

Nick Laudico/Zack Kubow

T
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NuVasive Completes Acquisition of Osteocel Biologics Business
2. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
3. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
4. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
5. NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
6. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
7. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
8. NuVasive to Host Investor Reception on September 11, 2007
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
11. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... TORONTO , June 2, 2015 /PRNewswire/ ... a clinical-stage company developing new therapeutics that target the ... Food and Drug Administration (FDA) has granted the company ... acute myeloid leukemia (AML). APTO-253, a first-in-class inducer of ... in a Phase Ib clinical trial in patients with ...
(Date:6/2/2015)... , June 02, 2015 Research and ... the "Bioburden Testing Market by Product , Test, ... report to their offering. The bioburden testing ... from $354.4 Million in 2014, growing at a CAGR ... basis of products, the microbial limit testing market is ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research ... the "Molecular Diagnostics - Global Market Size, Strategy ... their offering. "Molecular Diagnostics - Global Market ... data that analysts and planners can use. Hundreds of ... 2015 United States Medicare Fee Payment Schedules to help ...
(Date:6/2/2015)... , June 2, 2015 ... Inner Emotion Scanner. Scan & Read People. Analyze emotions ... & ART Concepts, including the very first Responsive-RPG: "The ... ) , , , , ... probe and truly affect your inner feelings - and ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Bioburden Testing Market 2015 - Global Forecasts to 2019 2Global Molecular Diagnostics Report 2015-2019 - Market Size, Strategy and Forecasts 2Global Molecular Diagnostics Report 2015-2019 - Market Size, Strategy and Forecasts 3ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3
... The inaugural  European Neurotech Investing & Partnering ... keynotes on the state of the European neurotech industry, investor ... next generation treatments emerging in the EU for unmet needs ... , s, addiction, depression, schizophrenia, Parkinson , ...
... it,s at the farthest end of the far infrared ... the airport to designing drugs to diagnosing skin cancer. Now, ... Energy,s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University ... of graphene the remarkable form of carbon that,s only ...
... PLAINFIELD, N.J. and CAMBRIDGE, Mass.,  Sept. 2, 2011 ... company, announced today the restructuring of their collaboration. ... for the U.S. and Canada and Genzyme held ... restructured agreement, PTC regains worldwide rights to ataluren ...
Cached Biology Technology:High-Level Neurotech Summit Brings Companies, Researchers and Investors Together in Helsinki 2High-Level Neurotech Summit Brings Companies, Researchers and Investors Together in Helsinki 3A whole new light on graphene metamaterials 2A whole new light on graphene metamaterials 3PTC Therapeutics and Genzyme Announce Restructuring of Collaboration 2PTC Therapeutics and Genzyme Announce Restructuring of Collaboration 3
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
(Date:5/7/2015)... GOTHENBURG, Sweden , May 7, 2015 /PRNewswire/ ... new touch fingerprint sensors, FPC1022 and FPC1035, FPC,s ... FPC1022 and FPC1035 are mainly considered for integration ... decreased size gives smartphone OEMs increased possibilities to ... portfolio. The decreased size also improves possibilities for ...
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... high standard of morality gives but a slight or ... over the other men of the same tribe...an advancement ... immense advantage to one tribe over another. ... explanation for morality and pro-social behaviors individuals behaving for ...
... new type of fuel cell powered with glucose derived ... the Inderscience Publication International Journal of Global Energy Issues. ... the glucose into hydrogen to power the cell, which ... resources, such as food waste and managed high-energy crops, ...
... Meets Growing Demand for High-Performance Notebook Computers ... and Consumer Electronic ... Products of,America, Inc., a leading supplier of innovative computer ... today,announced the launch of its MHZ2 BH series mobile ...
Cached Biology News:Group selection, a theory whose time has come...again 2Fujitsu Announces Industry Highest Capacity 2.5 Inch SATA Hard Disk Drive at 320GB(1) 2Fujitsu Announces Industry Highest Capacity 2.5 Inch SATA Hard Disk Drive at 320GB(1) 3
... end-users to be "a delight to use" ... microscopy and electronic imaging. With its ergonomic ... require much space and can easily be ... DM-BA300 combines Motic's own revolutionary Colour Corrected ...
... Motic's amazing new range of ergonomic ... and with a small footprint. The DM-BA200 ... Optical System and an exchangeable USB2.0 plug ... infinity-corrected E-Plan Achromat objectives mounted on a ...
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... Hamamatsu C9136 FLIM system combines the space and ... the resolution of the optical microscope to open ... short, pulsed light source for excitation, the decay ... the lifetime of the decay measured. Subtle ...
Biology Products: